Dementia clinical risk scores (CRSs) provide accessible tools for identifying individuals at risk for Alzheimer's disease (AD) and related dementias, yet their performance across diverse populations and relationships to AD endophenotypes remains unclear.
The impact of CKD transcriptional risk on AD endophenotypes is assessed by assessing the impact of CKD transcriptional risk on AD endophenotypes in individuals with chronic kidney disease.
Jung-Min Pyun, Young Ho Park, Jiyun Hwang et al.· Alzheimer's & Dementia· 0 citations
Amyloid positivity does not reliably predict near‐term cognitive decline in preclinical Alzheimer's disease (AD). We tested whether digital cognitive phenotyping improves prognostic precision.
C. Vanderlip, C. Stark· Alzheimer's & Dementia· 1 citation
A prognostic score (PS) summarizes a patient's expected disease progression and can increase the statistical efficiency of clinical trials when included as an analysis covariate.
B. T. Scodari, Roland Brown, Xiao-Tong Jiang et al.· Alzheimer's & Dementia· 0 citations
